
Fortuna Mining reports 69,665 gold equivalent ounces, keeps guidance
Séguéla needs 42,557 gold ounces in Q4 to hit its low-end annual target as Fortuna budgets US$109M for a plant expansion.

The infill interval sits inside the April resource model; a separate 106.5-metre intersection lies beyond the pit boundary.

Séguéla needs 42,557 gold ounces in Q4 to hit its low-end annual target as Fortuna budgets US$109M for a plant expansion.

Sasa lead output rose 21 per cent in the third quarter as higher head grades lifted production at the North Macedonia mine.
The 510(k) decision covers resting ECG use in adults and children, but HeartSciences has set no device launch date.
Shell guides Integrated Gas production at 740,000 to 780,000 boe/d and expects lower Marketing adjusted earnings.

Finland's environmental agency asked developer Tuike Finland to suspend land-altering preparation at Muhos and Kajaani by Oct. 23.

Nine-month test deliveries more than doubled, while third-quarter CyPath revenue awaits formal results.

Vaxcyte expects both underwritten offerings to close Oct. 9, adding funds for adult vaccine trials and manufacturing ahead of a planned U.S. filing.

PharmaLogic supplied doses to hospitals in Indiana and Ohio; Telix's Oct. 6 launch release gave no Pixclara sales target.
Auric paid A$6.5 million cash at settlement; A$3 million in shares awaits a vote, with up to A$7 million more tied to resource milestones.
The live application separates medical marijuana manufacturers, distributors and labs; state licences remain a condition of registration.
The Oct. 5 rule caps adult-use edibles at 10 milligrams per serving and 100 milligrams per package; medical edibles have higher caps.
An Oct. 6 SEC amendment identifies a SEDAR+ notice changing the bid's consideration and expiry after Curaleaf announced new cash and share terms.
The Oct. 1 cash subscription issued 926,784 WISeSat shares at US$10.79; a November price test could add up to 1,073,216 shares.
Blaize estimates Q3 revenue at US$0.5M and expects the remaining NeoTensr receivable to be paid in Q4.
Initial power availability is expected in 2028; the release names no tenant, power provider or construction budget.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
Funding for three plants depends on DOE conditions; Vistra's first extended uprate filing is planned for 2029.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The Oct. 5 placement issued 4.84 million shares at US$1.16 each and gave the placement agent warrants for another 387,464 shares.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Fiscal fourth-quarter revenue rose 68 per cent to US$567 million, with integrated memory supplying most of the dollar increase.
Black Hills plans US$1.8B of gas generation at Cheyenne Prairie, with energy service for Google's data centre due in late 2027.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
Canadian Utilities Class A holders other than ATCO would receive Emera shares, while ATCO holders would also get stock in a planned spinoff.

Gov. Abigail Spanberger filed to participate in Virginia's merger case, citing affordability, jobs and clean-energy concerns.

Prodigy and two First Nations chose BANR, but BWXT disclosed no contract value and has yet to sign a definitive development agreement.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
The 8.5 per cent property loan matures in April 2034 and puts cultivation sites in Johnstown and Palatka behind the debt.

The special committee will review formal materials before the board recommends a response; shareholders were told to take no action.

The Quebec grower has 15 of 24 Valleyfield rooms active and is still pursuing EU-GMP certification for its own processing centre.

The planned notice would lift cash to US$1 and the cap to US$6 per share, and extend the current Dec. 1 expiry to Dec. 4.